NO305865B1 - Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser - Google Patents

Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser

Info

Publication number
NO305865B1
NO305865B1 NO931627A NO931627A NO305865B1 NO 305865 B1 NO305865 B1 NO 305865B1 NO 931627 A NO931627 A NO 931627A NO 931627 A NO931627 A NO 931627A NO 305865 B1 NO305865 B1 NO 305865B1
Authority
NO
Norway
Prior art keywords
compounds
heteroatomic
pharmaceutical preparations
tricyclic
tricyclic compounds
Prior art date
Application number
NO931627A
Other languages
English (en)
Norwegian (no)
Other versions
NO931627D0 (no
NO931627L (no
Inventor
Karl Baumann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO931627D0 publication Critical patent/NO931627D0/no
Publication of NO931627L publication Critical patent/NO931627L/no
Publication of NO305865B1 publication Critical patent/NO305865B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
NO931627A 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser NO305865B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (3)

Publication Number Publication Date
NO931627D0 NO931627D0 (no) 1993-05-05
NO931627L NO931627L (no) 1993-11-08
NO305865B1 true NO305865B1 (no) 1999-08-09

Family

ID=26300836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931627A NO305865B1 (no) 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser

Country Status (25)

Country Link
US (1) US5514685A (fr)
EP (1) EP0569337B1 (fr)
JP (1) JP2788392B2 (fr)
KR (1) KR100292311B1 (fr)
CN (1) CN1037773C (fr)
AT (1) ATE155787T1 (fr)
AU (1) AU668152B2 (fr)
CA (1) CA2095659C (fr)
CY (1) CY2126B1 (fr)
CZ (1) CZ291773B6 (fr)
DE (1) DE69312386T2 (fr)
DK (1) DK0569337T3 (fr)
ES (1) ES2105193T3 (fr)
FI (2) FI102612B (fr)
GR (1) GR3024754T3 (fr)
HU (2) HUT66531A (fr)
IL (1) IL105607A (fr)
MY (1) MY109602A (fr)
NO (1) NO305865B1 (fr)
NZ (1) NZ247553A (fr)
PH (1) PH30456A (fr)
RU (1) RU2126009C1 (fr)
SG (1) SG47011A1 (fr)
SK (1) SK282061B6 (fr)
TW (1) TW330936B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
GB9421613D0 (en) * 1994-10-26 1994-12-14 Sandoz Ltd Organic compounds
IL129547A (en) 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
CN100335063C (zh) 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物
ME00189B (me) 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
CA2326222C (fr) * 1998-04-27 2008-09-23 Fujisawa Pharmaceutical Co., Ltd. Compositions medicinales
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
RU2206298C2 (ru) * 2000-09-22 2003-06-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ лечения глаукомы
EP1531793A1 (fr) 2002-07-23 2005-05-25 Novartis AG Composition d'onguent ophtalmique comprenant un medicament, une base d'onguent et un agent de solubilisation/dispersion
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
WO2011121105A1 (fr) * 2010-04-02 2011-10-06 Tibotec Pharmaceuticals Inhibiteurs de l'intégrase macrocyclique
US10143682B2 (en) 2014-10-28 2018-12-04 Koushi Yamaguchi Medicine for improving state of pregnancy, and use thereof
US20210228551A1 (en) 2018-08-10 2021-07-29 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in maternofetal relationship
CN120053439A (zh) 2018-12-18 2025-05-30 山口晃史 用于改善不孕不育症或妊娠状态的药物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives
US4952605A (en) * 1983-08-03 1990-08-28 The Regents Of The University Of California Manoalide analogs
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA1316916C (fr) * 1988-10-12 1993-04-27 David Askin Produit du rearrangement du fk-506 par l'entremise d'un hydroxyde
DE68904037T2 (de) * 1988-10-12 1993-06-03 Merck & Co Inc Verfahren zur umlagerung von fk-506 unter beteiligung von hydroxid.
JPH07108101B2 (ja) * 1989-02-28 1995-11-15 オ−クマ株式会社 リニアアクチュエータ駆動制御装置
KR920700212A (ko) * 1989-06-14 1992-02-19 쟝 크라머·한스 루돌프 하우스 헤테로원자-함유 트리사이클릭 화합물
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
JPH06500102A (ja) * 1990-08-18 1994-01-06 フアイソンズ・ピーエルシー マクロ環状化合物
EP0480623A1 (fr) * 1990-10-11 1992-04-15 Merck & Co. Inc. Halomacrolides et dérivés ayant une activité immunosuppressive
WO1992013862A1 (fr) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Composes de lactone
ES2179823T3 (es) * 1991-09-05 2003-02-01 Abbott Lab Inmunosupresor macrolido.

Also Published As

Publication number Publication date
HUT66531A (en) 1994-12-28
IL105607A0 (en) 1993-09-22
FI102612B1 (fi) 1999-01-15
GR3024754T3 (en) 1997-12-31
NO931627D0 (no) 1993-05-05
EP0569337B1 (fr) 1997-07-23
ES2105193T3 (es) 1997-10-16
HU211135A9 (en) 1995-10-30
AU668152B2 (en) 1996-04-26
SK43593A3 (en) 1995-07-11
TW330936B (en) 1998-05-01
CA2095659C (fr) 2005-08-09
AU3839393A (en) 1993-11-11
NO931627L (no) 1993-11-08
DE69312386T2 (de) 1998-01-29
CA2095659A1 (fr) 1993-11-08
JPH0641144A (ja) 1994-02-15
DK0569337T3 (da) 1998-01-19
FI982476A0 (fi) 1998-11-16
KR940005631A (ko) 1994-03-22
MY109602A (en) 1997-03-31
NZ247553A (en) 1995-07-26
PH30456A (en) 1997-05-28
FI982476A7 (fi) 1998-11-16
RU2126009C1 (ru) 1999-02-10
CZ82993A3 (en) 1994-01-19
FI932035A0 (fi) 1993-05-05
CN1037773C (zh) 1998-03-18
IL105607A (en) 1998-01-04
JP2788392B2 (ja) 1998-08-20
CN1083486A (zh) 1994-03-09
EP0569337A1 (fr) 1993-11-10
FI932035A7 (fi) 1993-11-08
CZ291773B6 (cs) 2003-05-14
US5514685A (en) 1996-05-07
CY2126B1 (en) 2002-06-21
SG47011A1 (en) 1998-03-20
DE69312386D1 (de) 1997-08-28
FI102612B (fi) 1999-01-15
SK282061B6 (sk) 2001-10-08
ATE155787T1 (de) 1997-08-15
HU9301190D0 (en) 1993-07-28
KR100292311B1 (ko) 2001-09-17

Similar Documents

Publication Publication Date Title
NO305865B1 (no) Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser
PL300068A1 (en) 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
CO4290353A1 (es) Agonistas de estrogeno
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
NO307985B1 (no) Farmasøytiske preparater samt anvendelse av syklopeptider ved fremstilling av medikamenter
FI961418L (fi) Atsolijohdannainen ja sen farmaseuttinen seos
NO308302B1 (no) Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav
NO308607B1 (no) Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
ITMI931685A1 (it) Derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
DE69432756D1 (de) 1,3-oxazin-4-on-derivate, verfahren und zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
NO962243D0 (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
NO178540C (no) Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
FI953106A0 (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
ITMI930819A0 (it) Derivati eterobiciclici ad attivita' fungicida
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
DK0654028T3 (da) 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af lægemidler
DE69402988D1 (de) SmFeTa Legierung mit 4-5 at% Ta Zusatz und dessen Herstellungsverfahren
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees